INLBItem 9 Labs Corp.

About Item 9 Labs Corp. (INLB)

Item 9 Labs Corp. (INLB) is a Drug Manufacturers - Specialty & Generic company headquartered in Phoenix, AZ, United States whose shares trade over-the-counter on the Expert Market tier.

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. For additional information, visit item9labscorp.com.

Products and services

Through a licensing agreement, the Company grows marijuana and produces cannabis related products at their facility in Pinal County, Arizona on behalf of a licensed marijuana dispensary in the state of Arizona. In March 2021, the Company closed on the acquisition of OCG, Inc, dba Unity Rd, a dispensary franchisor. The transaction was structured as a reverse triangular merger, with the effect of OCG, Inc. becoming a wholly owned subsidiary of the Company. Unity Rd has agreements with more than fifteen (15) entrepreneurial groups to open more than thirty (30) Unity Rd retail dispensary locations in 7 states. Unity Rd will be the vehicle to bring Item 9 Labs products across the United States and internationally, while keeping dispensaries locally owned and operated, empowering entrepreneurs to confidently and successfully operate their business and contribute to their local communities. As the Unity Rd dispensaries achieve sufficient market penetration, Item 9 Labs aims to offer its products in those locations to expand the distribution footprint of its premium product offerings.

INLB key facts

Ticker symbol

INLB

Market tier

Expert Market

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Phoenix, AZ, United States

Country of incorporation

US

Year of incorporation

2010

Employees

99

Estimated market cap

$70.2K (as of May 31, 2024)

Shares outstanding

701,806,041

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

9/30

Latest filing

8K Report (Jul 20, 2023)

Item 9 Labs Corp. leadership

• Chris Leland Wolven — COO
• Robert (Bobby) Edward Mikkelsen — CFO
• Jessica M. Lockett — Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with I